Metraipolis › archive › dc_d260b8978bf0
Standard dose and low-dose rituximab combined with glucocorticoids and cyclophosphamide in the treatment of acquired haemophilia A — Europe PMC PMID:40948798
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40948798
- DOI
- 10.3389/fimmu.2025.1642982
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T06:55:37.130Z
- SHA-256 of the archived text
5699c8786032b62b0b7246dd9d3a042d9e545383cf68b9b1d4a27bab56108a4a- Stable URL of this page
https://metraipolis.com/documento/dc_d260b8978bf0
How to cite
Standard dose and low-dose rituximab combined with glucocorticoids and cyclophosphamide in the treatment of acquired haemophilia A — Europe PMC PMID:40948798 — Europe PMC (en), https://europepmc.org/article/MED/40948798 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d260b8978bf0 (Metraipolis archive dc_d260b8978bf0, sha256 5699c8786032b62b0b7246dd9d3a042d9e545383cf68b9b1d4a27bab56108a4a)
BibTeX
@misc{dcd260b8978bf0,
title = {Standard dose and low-dose rituximab combined with glucocorticoids and cyclophosphamide in the treatment of acquired haemophilia A — Europe PMC PMID:40948798},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40948798},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d260b8978bf0; sha256 5699c8786032b62b0b7246dd9d3a042d9e545383cf68b9b1d4a27bab56108a4a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40948798. Agents can read the archived copy with the MCP tool read_document.